Advertisement

Journal of Parasitic Diseases

, Volume 40, Issue 3, pp 981–985 | Cite as

IL-18 gene polymorphism in patients with visceral leishmaniasis in East Azarbaijan, Iran

  • Ehsan Ahmadpour
  • Ahad Bazmani
  • Mohamad Hasan Kohansal
  • Abdolhasan Kazemi
  • Zohre Babaloo
Original Article
  • 150 Downloads

Abstract

Visceral leishmaniasis (VL) is a parasitic disease caused by Leishmania species. According to the important role of cellular immunity against VL, this study was directed to determine the frequency of −607A/C and −137G/C genotypes on promoter region of interleukin-18 gene. The study groups included 91 patients with confirmed history of VL, 106 healthy seronegative, and 79 healthy seropositive individuals. All three groups were analyzed by amplification refractory mutation system polymerase chain reaction (ARMS-PCR). The highest rate of −607/A, and −607/C alleles was observed in seronegative individuals (66/67 %) and in the patients (72/83 %). Allele frequency of −607/C is more than −607/A allele in all groups. In position of −137, frequency of −137/G allele in all groups was more than −137/C. Statistical analysis of distribution of genotypes, did not reveal any significant difference among groups. On the basis of the results, there was no significant association between VL and polymorphism of IL-18 promoter. The results of this study showed that IL-18 gene promoter polymorphisms at positions −607 and −137 are not associated with VL in East Azerbaijan, Iran.

Keywords

Interleukin-18 Visceral leishmaniasis ARMS-PCR East Azerbaijan Iran 

Notes

Acknowledgments

This project was supported by a grant from the Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences.

Conflict of interests

The authors declare that there is no conflict of interests.

References

  1. Cai G, Kastelein R, Hunter CA (2000) Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect Immun 68(12):6932–6938CrossRefPubMedPubMedCentralGoogle Scholar
  2. Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27(5):305–318CrossRefPubMedGoogle Scholar
  3. Fallah M, Bazmani A (2008) Association between endothelial selectin (E-Selectin) gene polymorphisms and E-selectin level with visceral leishmaniais, in an ARMS-PCR based study. Iran J Parasitol 3(4):23–31Google Scholar
  4. Hajilooi M et al (2014) Is the polymorphism at position -1082 of IL-10 gene associated with visceral leishmaniasis? Iran J Public Health 43(8):1107–1112PubMedPubMedCentralGoogle Scholar
  5. Hamidi M, Hajilooei M, Bazmani A (2013) Association of transforming growth factor-Î21 gene polymorphism with visceral leishmaniasis in an Iranian population. Shiraz E Med J 14(2):123–129Google Scholar
  6. Harishankar M, Selvaraj P, Rajeswari DN, Anand SP, Narayanan PR (2007) Promoter polymorphism of IL-18 gene in pulmonary tuberculosis in South Indian population. Int J Immunogenet 34(5):317–320CrossRefPubMedGoogle Scholar
  7. Kojima S, Nagamine Y, Hayano M, Looareesuwan S, Nakanishi K (2004) A potential role of interleukin 18 in severe falciparum malaria. Acta Trop 89(3):279–284CrossRefPubMedGoogle Scholar
  8. Lee YJ et al (2006) Interleukin-18 promoter polymorphisms in patients with Behcet, s disease. Hum Immunol 67(10):812–818CrossRefPubMedGoogle Scholar
  9. Leung WK et al (2006) H. pylori genotypes and cytokine gene polymorphisms influence the development of gastric intestinal metaplasia in a Chinese population. Am J Gastroenterol 101(4):714–720CrossRefPubMedGoogle Scholar
  10. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215CrossRefPubMedPubMedCentralGoogle Scholar
  11. Mohebali M (2013) Visceral leishmaniasis in Iran: review of the epidemiological and clinical features. Iran J Parasitol 8(3):348PubMedPubMedCentralGoogle Scholar
  12. Naeimi S, Ghiam AF, Mojtahedi Z, Dehaghani AS, Amani D, Ghaderi A (2006) Interleukin-18 gene promoter polymorphisms and recurrent spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 128(1):5–9CrossRefPubMedGoogle Scholar
  13. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19(1):423–474CrossRefPubMedGoogle Scholar
  14. Oshaghi MA et al (2009) Vector incrimination of sand flies in the most important visceral leishmaniasis focus in Iran. Am J Trop Med Hyg 81(4):572–577CrossRefPubMedGoogle Scholar
  15. Reddy P (2004) Interleukin-18: recent advances. Curr Opin Hematol 11(6):405–410CrossRefPubMedGoogle Scholar
  16. Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2(11):845–858CrossRefPubMedGoogle Scholar
  17. Vanloubbeeck Y, Jones DE (2004) The immunology of Leishmania infection and the implications for vaccine development. Ann N Y Acad Sci 1:267–272CrossRefGoogle Scholar
  18. Wei X-Q, Niedbala W, Xu D, Luo Z-X, Pollock KGJ, Brewer JM (2004) Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. Immunol Lett 94(1):35–37CrossRefPubMedGoogle Scholar

Copyright information

© Indian Society for Parasitology 2014

Authors and Affiliations

  • Ehsan Ahmadpour
    • 1
    • 2
  • Ahad Bazmani
    • 2
  • Mohamad Hasan Kohansal
    • 3
  • Abdolhasan Kazemi
    • 4
  • Zohre Babaloo
    • 5
  1. 1.Toxoplasmosis Research CenterMazandaran University of Medical SciencesSariIran
  2. 2.Infectious and Tropical Diseases Research CenterTabriz University of Medical SciencesTabrizIran
  3. 3.Department of Medical Parasitology and Mycology, School of MedicineZanjan University of Medical SciencesZanjanIran
  4. 4.Drug Applied Research Center, Department of Medical Parasitology and MycologyTabriz University of Medical SciencesTabrizIran
  5. 5.Immunology Research CenterTabriz University of Medical SciencesTabrizIran

Personalised recommendations